Skip navigation

Chemical Amides

1–50 of 4,969 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin cell cycle 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin results in decreased cell cycle 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
8 genes: BUB1B | CCND1 | CDK4 | CDKN1A | CDKN1B | CHEK1 | PTTG1 | TP53
1
2. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin apoptotic process 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
9 genes: BUB1B | CASP3 | CASP9 | CHEK1 | HMOX1 | PARP1 | RAF1 | TNF | TP53
1
3. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin apoptotic process vorinostat [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin co-treated with vorinostat] results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
9 genes: BUB1B | CASP3 | CASP9 | CHEK1 | HMOX1 | PARP1 | RAF1 | TNF | TP53
1
4. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin apoptotic process vorinostat [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin co-treated with vorinostat] results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Tumor Cells, Cultured
9 genes: BUB1B | CASP3 | CASP9 | CHEK1 | HMOX1 | PARP1 | RAF1 | TNF | TP53
1
5. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin cell proliferation Rotenone 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Rotenone results in decreased cell proliferation] 1: Homo sapiens Neurons | Cell Line, Tumor
7 genes: ALK | BUB1B | CDK4 | MYC | RAF1 | TNF | TP53
1
6. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin reactive oxygen species metabolic process Rotenone 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Rotenone results in increased reactive oxygen species metabolic process] 1: Homo sapiens Neurons | Cell Line, Tumor   1
7. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin cell proliferation Cadmium Chloride 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Cadmium Chloride results in decreased cell proliferation] 1: Oncorhynchus mykiss Liver | Cell Line, Tumor
7 genes: ALK | BUB1B | CDK4 | MYC | RAF1 | TNF | TP53
1
8. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin creatine kinase activity Lipopolysaccharides 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased creatine kinase activity] 1: Rattus norvegicus Plasma   1
9. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin lactate dehydrogenase activity Lipopolysaccharides 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased lactate dehydrogenase activity] 1: Rattus norvegicus Plasma   1
10. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin creatine kinase activity Lipopolysaccharides | Quercetin Quercetin inhibits the reaction [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased creatine kinase activity]] 1: Rattus norvegicus Plasma   1
11. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin nitric oxide metabolic process Lipopolysaccharides 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased nitric oxide metabolic process] 1: Rattus norvegicus Plasma   1
12. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin nitric oxide metabolic process Lipopolysaccharides | Quercetin Quercetin inhibits the reaction [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased nitric oxide metabolic process]] 1: Rattus norvegicus Plasma   1
13. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin superoxide anion generation Lipopolysaccharides 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased superoxide anion generation] 1: Rattus norvegicus Heart Ventricles | Myocardium   1
14. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin glutathione biosynthetic process Lipopolysaccharides [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin co-treated with Lipopolysaccharides] results in increased glutathione biosynthetic process 1: Rattus norvegicus Heart Ventricles | Myocardium   1
15. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin leukocyte migration involved in inflammatory response Lipopolysaccharides 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased leukocyte migration involved in inflammatory response] 1: Rattus norvegicus Lung | Pulmonary Alveoli   1
16. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin leukocyte migration involved in inflammatory response Lipopolysaccharides | Quercetin Quercetin inhibits the reaction [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased leukocyte migration involved in inflammatory response]] 1: Rattus norvegicus Lung | Pulmonary Alveoli   1
17. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin positive regulation of apoptotic DNA fragmentation arsenic trioxide [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin co-treated with arsenic trioxide] results in increased positive regulation of apoptotic DNA fragmentation 1: Rattus norvegicus Osteoblasts | Cells, Cultured   1
18. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide eosinophil extravasation Formaldehyde | Ovalbumin 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [[Ovalbumin co-treated with Formaldehyde] results in increased eosinophil extravasation] 1: Mus musculus Lung   1
19. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide neutrophil extravasation Formaldehyde | Ovalbumin 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [[Ovalbumin co-treated with Formaldehyde] results in increased neutrophil extravasation] 1: Mus musculus Lung   1
20. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide interleukin-4 secretion Formaldehyde | Ovalbumin 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [[Ovalbumin co-treated with Formaldehyde] results in increased interleukin-4 secretion] 1: Mus musculus Lung   1
21. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide interleukin-1 beta secretion Formaldehyde | Ovalbumin 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [[Ovalbumin co-treated with Formaldehyde] results in increased interleukin-1 beta secretion] 1: Mus musculus Lung   1
22. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide necrotic cell death carvacrol | irinotecan 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased necrotic cell death]] 1: Mus musculus Jejunum   1
23. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inflammatory response carvacrol | irinotecan 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased inflammatory response]] 1: Mus musculus Jejunum
5 genes: IL13 | IL1B | IL5 | TAC1 | TNF
1
24. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide glutathione biosynthetic process carvacrol | irinotecan 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in decreased glutathione biosynthetic process]] 1: Mus musculus Jejunum   1
25. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide lipid catabolic process carvacrol | irinotecan 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased lipid catabolic process]] 1: Mus musculus Jejunum   1
26. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide nitric oxide biosynthetic process carvacrol | irinotecan 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased nitric oxide biosynthetic process]] 1: Mus musculus Jejunum   1
27. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide positive regulation of cytosolic calcium ion concentration allyl isothiocyanate 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [allyl isothiocyanate results in increased positive regulation of cytosolic calcium ion concentration] 1: Rattus norvegicus HEK293 Cells
3 genes: CXCL1 | IL1B | TAC1
1
28. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide transepithelial transport allyl isothiocyanate 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [allyl isothiocyanate results in increased transepithelial transport] 1: Mus musculus Colon | Intestinal Mucosa   1
29. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide swimming behavior Particulate Matter 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [Particulate Matter affects swimming behavior] 1: Danio rerio     1
30. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide swimming behavior Vehicle Emissions 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [Vehicle Emissions affects swimming behavior] 1: Danio rerio     1
31. 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide swimming behavior Acrolein 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [Acrolein affects swimming behavior] 1: Danio rerio     1
32. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine cell death palbociclib [palbociclib results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased cell death 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
2 genes: CDKN1B | OPTN
1
33. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine cell proliferation 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased cell proliferation 1: Homo sapiens Blood | Cell Line, Tumor
46 genes: AKT1 | AR | AREG | BAD | BAX | BCL2 | BOK | BOP1 | CDC25A | CDK1 | CDK5R1 | CITED2 | DKC1 | EGFR | EHF | EIF4B | ELF5 | ERBB2 | FOXN1 | GSK3B | HHEX | IGF1 | IL18 | INSIG1 | IRS2 | MAP2K1 | MCM10 | MET | MYC | NRG1 | PA2G4 | PDK1 | PDXK | PIM1 | POLR3G | PRKDC | PTEN | SKP2 | STAT3 | TCF19 | TNF | TP53 | UBR5 | UHRF1 | VEGFA | YPEL5
1
34. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine positive regulation of cell death 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased positive regulation of cell death 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
5 genes: ACOX2 | BCL2L11 | CDKN1A | CDKN1B | MTOR
1
35. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine positive regulation of cell death 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased positive regulation of cell death 1: Mus musculus Mammary Glands, Animal | Cells, Cultured
5 genes: ACOX2 | BCL2L11 | CDKN1A | CDKN1B | MTOR
1
36. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide cell proliferation Cadmium 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [Cadmium results in increased cell proliferation] 1: Homo sapiens MCF-7 Cells
6 genes: CD70 | CDK1 | FGF1 | IGF1 | NRG1 | PCNA
1
37. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide regulation of nucleus size 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide affects regulation of nucleus size 1: Homo sapiens Skin | Cell Line, Tumor   1
38. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process MCL1 | sorafenib MCL1 protein inhibits the reaction [[sorafenib co-treated with 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide] results in increased apoptotic process] 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
39. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process sorafenib [sorafenib co-treated with 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide] results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
40. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process BCL2 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide promotes the reaction [BCL2 mutant form results in increased apoptotic process] Bone Marrow | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
41. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide promotes the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate results in increased apoptotic process] Bone Marrow | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
42. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process BCL2 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [BCL2 inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate results in increased apoptotic process]] Bone Marrow | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
43. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide cell proliferation ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide promotes the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate results in decreased cell proliferation] Bone Marrow | Cell Line, Tumor
6 genes: CTNNB1 | EGFR | MAP2K1 | MKI67 | RAF1 | STAT3
1
44. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide cell proliferation 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased cell proliferation 1: Homo sapiens Schwann Cells | Cell Line, Tumor
6 genes: CTNNB1 | EGFR | MAP2K1 | MKI67 | RAF1 | STAT3
1
45. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide cell proliferation 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased cell proliferation 1: Homo sapiens Neurons | Cell Line, Tumor
6 genes: CTNNB1 | EGFR | MAP2K1 | MKI67 | RAF1 | STAT3
1
46. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in increased apoptotic process 1: Homo sapiens Neurons | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
47. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in increased apoptotic process 1: Homo sapiens Schwann Cells | Cell Line, Tumor
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
48. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide cell cycle 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased cell cycle 1: Homo sapiens Schwann Cells | Cell Line, Tumor
6 genes: AHR | DDIT3 | MAPK1 | MAPK3 | MKI67 | RPS6KB1
1
49. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide cell cycle 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased cell cycle 1: Homo sapiens Neurons | Cell Line, Tumor
6 genes: AHR | DDIT3 | MAPK1 | MAPK3 | MKI67 | RPS6KB1
1
50. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide apoptotic process 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in increased apoptotic process 1: Homo sapiens Schwann Cells | Cells, Cultured
12 genes: AHR | AIFM1 | CASP3 | CASP9 | DDIT3 | MAPK1 | MAPK3 | MCL1 | RAF1 | RPS6KB1 | TP53AIP1 | TP73
1
1–50 of 4,969 results.